SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: NeoStem (NBS) sells 51% interest in Chinese generic pharma

No earlier versions found for this Subject.


Return to NeoStem (NBS) sells 51% interest in Chinese generic pharma
 
Great news of the month for NeoStem: stock prices will surely move upwards with the announcement of the sale of their ownership in Suzhou Erye. With $12.3 million to be gained initially from this sale, NBS will now be able to cut expenses and focus their efforts more closely on their research. Major gains to be seen and an increase in cash flow.

news.yahoo.com

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News